Skip to content

Integra LifeSciences IART Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

AbbVie logo
AbbVieABBV
ITG
Integer HoldingsITGR
CONMED logo
CONMEDCNMD
Boston Scientific logo
Boston ScientificBSX
ICU Medical logo
ICU MedicalICUI
Establishment Labs logo
Establishment LabsESTA

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's treasury stock, shares (in shares)?
Integra LifeSciences (IART) reported treasury stock, shares (in shares) of $14.36M in Q1 2026.
How has Integra LifeSciences's treasury stock, shares (in shares) changed year-over-year?
Integra LifeSciences's treasury stock, shares (in shares) decreased by 0.5% year-over-year, from $14.42M to $14.36M.
What is the long-term trend for Integra LifeSciences's treasury stock, shares (in shares)?
Over 5 years (2020 to 2025), Integra LifeSciences's treasury stock, shares (in shares) has grown at a 24.1% compound annual growth rate (CAGR), from $4.9M to $14.4M.